Merck has launched the Chemisphere app, a digital tool that enables scientists to easily access product documentation and ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Qiagen (QGEN – Research Report) and Merck & Company (MRK – Research Report). Claim 50% Off Ti ...

Merck & Co., Inc. (MRK), based in Rahway, New Jersey, is a healthcare company. Valued at $264.2 billion by market cap, the company delivers health solutions through its prescription medicines, ...

Goldman Sachs analyst Chris Shibutani maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of $131.00. Chris Shibutani has given his Buy rating to Merck & ...

In the latest market close, Merck (MRK) reached $106.64, with a +0.28% movement compared to the previous day. The stock's change was more than the S&P 500's daily loss of 0.05%. Meanwhile, the Dow ...

In a report released on January 16, Steve Scala from TD Cowen maintained a Hold rating on Merck & Company, with a price target of $120.00. The company’s shares closed last Friday at $108.83. Scala ...

Merck KGaA is an undervalued pharma company with a long history and strong fundamentals. The company has above-average margins and a diverse business portfolio in healthcare, life sciences, and ...

The company’s previous CCO was Cristal Downing, who joined Insulet as chief corporate affairs officer late last year.

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) shares are trading higher on Monday after the company inked a deal to be acquired by Merck & Company, Inc. (NYSE:MRK) for $47 per share in cash. The ...

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

Merck (known as MSD outside of the United States and Canada) will complete its $9.2 billion acquisition of Cidara Therapeutics, bringing CD388, a late-stage flu antiviral, into its pipeline and aimed ...